MarineMax (HZO, $700M cap) is a premium boat retailer in the back half of an inventory cycle. Donerail Group submitted a $1.1B all-cash LBO bid at $35/share in February 2026 and went principal at ≈4% stake. The Q2 FY2026 10-Q filed April 23 is the first periodic filing covering the post-bid period — and management never mentions the bid, the strategic review, or any board response.

They didn't have to. The 10-Q tells you anyway, in one footnote line.

What the filing says

Q2 FY2026 (quarter ended March 31, 2026):

• Revenue $527M (-16.5% YoY) but gross margin 34.4% vs 30.0% PY (+440 bps) — driven by mix shift to higher-margin marina/storage/F&I/brokerage businesses, now 37.7% of revenue
• Customer deposits $61.7M, highest since the inventory overhang began (+$16M sequential, +$4.8M YoY). Cash flow statement shows contract liabilities provided $16M of operating cash inflow in H1 vs $7M drain PY
• Operating cash flow +$72M H1 vs -$74M PY — $146M swing
• Cash $189M, floor plan financing -16% YoY at $690M
• Total inventory -$128M YoY at $845M

The signal that wasn't in the MD&A:

In the SG&A footnote (line 1631): "transaction and other costs ($5.7 million and $0.6 million)" for the respective Q2 periods. Q2 FY2026 transaction costs are 9.5x the prior year level. H1 cumulative: $8.7M vs $0.8M. Not explained anywhere in the narrative sections.

Three concurrent fingerprints reinforce the read:

• FY2026 guidance withdrawn. Q1 10-Q (Jan 30) reaffirmed $110-125M adj EBITDA. Q2 10-Q contains zero forward guidance — unprecedented mid-year withdrawal without explanation
• Zero share repurchases (vs $12.4M in Q2 FY2025 and a long history of aggressive buybacks)
• Sixth Amendment to credit facility (Jan 26, 2026, one month before the bid) loosened the FCCR covenant from 1.10x to 1.05x AND added a "USCBP Special Program Inventory" definition for goods imported under Temporary Importation under Bond and Foreign Trade Zone programs

What the market thinks

Donerail bid $35/share — the premium to current price hasn't been fully priced in.

If the assumed no-deal floor is $25 (pre-bid level), market-implied P(deal) = 47%. If the assumed floor is $28 (recent fundamental support), market-implied P(deal) = 25%. Analyst consensus 7 Buy / 2 Hold, mean target $33. Options structure bullish: P/C 0.33, IV 62.6% (66th %ile), max pain $30. Short interest 20.2%, days-to-cover 8.4.

Why the gap exists

Investment bank M&A retainers (Goldman, Morgan Stanley) and legal fees (Wachtell, Skadden) cannot legally be hidden in COGS or below-the-line — accounting rules force them into the SG&A footnote. A 9.5x jump in this line item with the company silent about strategic alternatives in narrative sections is the cleanest fingerprint of an active process management cannot publicly discuss. The footnote line item is read by ~zero retail analysts and few sell-side.

Cross-ticker confirmation surfaced separately: MarineMax peer MCFT (premium boat OEM) reported the exact same +440 bps gross margin improvement in their corresponding quarter — channel-wide premium recovery, not HZO accounting noise. ONEW deposits went the opposite direction (down $28M YoY) while HZO deposits were up $5M, indicating premium share is consolidating into MarineMax at the deposit stage. The MBUU peer printed -540 bps as the share donor.

The TIB/FTZ language in the credit facility is industry-unique. Searches for USCBP, TIB, Foreign Trade Zone, and temporary importation returned zero matches across ONEW, MBUU, MCFT, and BC. HZO is the only large public marine retailer with material European import exposure (Azimut, Galeon, Princess) — and the only one with the bonded-import infrastructure to arbitrage it. This reframes the $48.5M sequential spike in in-transit inventory from "unhedged tariff exposure" to "unique competitive infrastructure."

Director coordinated buying November 14, 2025: 5 directors each bought 4,633 shares at $29.71 — pre-bid, at what became the strategic floor.

Forward EV

Probability-weighted: +6.6% over 12mo. 70/30 positive skew.

The take-private bid is the loudest piece, but contributes only +1.5% of the +6.6% mean EV. The other +5% comes from underlying margin recovery, deposit-stage share take from ONEW, tariff-infrastructure moat, and IEEPA refund optionality. The trade survives a no-deal outcome — termination scenario is only -12% because fundamental tailwinds offset most of the bid-premium loss.

Risks (ranked)

1. Modal outcome is dead money. 40% scenario is "still in review" with stock grinding $28-32 for 6+ months. Catalyst alpha decays ≈0.6%/day past December.
2. Termination scenario. 22% probability board terminates without transaction. Stock retraces -12% to $26.
3. Macro deterioration. Iran conflict named in MD&A for first time in HZO history. Recession + tariff escalation could push the 8% bid_withdrawn scenario to materialize at -29%.
4. Idio variance only 57-72% depending on factor specification — below the 75% target. Small-cap (IWM 43%) and consumer disc (XLY 21%) are dominant spanned factors.
5. In-transit inventory conversion. $48.5M sequential spike could land on the floor plan if Q3 demand disappoints.

Catalysts

• ~May 9-13: ONEW Q2 FY26 10-Q — share-take test (cross-ticker)
• July 23: HZO Q3 FY2026 earnings — primary decision point (margin durability + guidance reinstatement)
• Q3-Q4: Possible Donerail 13D/A amendment or HZO 8-K Item 8.01 (Special Committee formation)
• December 31: Take-private resolution deadline
• August 2027: Credit facility maturity forces resolution

What would change our mind

• Donerail 13D/A reducing stake → capital flight, thesis-killer
• HZO 8-K announcing "process concluded, committed to standalone strategy" without Special Committee → catalyst dead
• Q3 gross margin <28% → margin recovery thesis broken
• Q3 customer deposits decline >$10M sequentially → share-take reverses
• ONEW Q2 deposits print >$53.5M → competitive consolidation thesis weakens; HZO is merely ahead of cycle, not taking share
• Topping bid disclosed → return distribution shifts toward $38-42

Evidence

Memo LR: 1.5. Bullish with bounded conviction. The take-private bid is real and the process is clearly active (the SG&A footnote proves it), but the modal outcome is dead money for 6+ months and the binary kicker is one scenario of four. The fundamental cycle and share-take story underwriting the 70/30 positive skew is what makes this trade survive a no-deal outcome.